Pfizer says its vaccine targeting Omicron will be ready in March
CBSN
Pfizer will have a COVID-19 vaccine that specifically targets the Omicron variant ready by March, the pharmaceutical company's chief executive said Monday.
Pfizer CEO Albert Bourla said the company has already begun manufacturing a new version of its COVID-19 vaccine that aims to protect recipients against Omicron. "This vaccine will be ready in March," he told CNBC's "Squawk Box" on Monday. "We [are] already starting manufacturing some of these quantities at risk."

A jury on Wednesday found that Meta and YouTube are liable for creating products that led to harmful and addictive behavior by young users, a landmark decision that could set a legal precedent for similar allegations brought against social media companies. Edited by Alain Sherter and Aimee Picchi In:

An internal watchdog report in the Department of Homeland Security identified serious vulnerabilities in TSA's screenings at airports nationwide — and the agency has yet to respond five months later, according to internal communications provided to House Homeland Security Committee staff and reviewed by CBS News.











